Cobalis Corp. (fka CLSC)

[ScaryStocks]

With a $3 billion market, the potential for CLSC is huge. This is the type of news for CLSC that Mike has been hinting about for some time. One can only hope.

From the Inspire and FAES news release:

"About Rhinitis

Rhinitis is a condition that primarily results from exposure to allergens, either at specific times of the year (seasonal allergic rhinitis) or year-round (perennial allergic rhinitis), or from exposure to irritants, such as cigarette smoke or perfume. Symptoms most often include nasal congestion or stuffiness, rhinorrhea (runny nose) and nasal itching. In the United States, allergic rhinitis affects approximately 40 million people, according to the American Academy of Allergy, Asthma & Immunology. Annual sales of oral antihistamine products to treat allergic rhinitis are estimated by IMS Health to total more than $3 billion."